Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/6/915/484123/mdi195.pdf
Reference18 articles.
1. Epidemiology and non genetic causes of breast cancer;Willett,2000
2. Benefit of a high dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognosis factors: five year follow-up results of FASG 05 randomised trial;French Adjuvant Study Group;J Clin Oncol,2001
3. Epirubicin 100mg/m2 per cycle increases long-term survival in adjuvant chemotherapy of patients with poor prognosis, node positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial;Bonneterre;J Clin Oncol,2005
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer;The Breast;2021-08
2. APPLICATION OF SENSITIVITY ANALYSIS FOR EVALUATION OF FACTORS DETERMINING THE ENTERPRISES COST OF PRODUCTION;Market Infrastructure;2020-08
3. Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France;PLOS ONE;2015-06-18
4. Analyse coût-efficacité d’un test prédictif de la chimiothérapie dans le cancer du sein (Oncotype DX®) en France;Bulletin du Cancer;2012-10
5. A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study;Annals of Oncology;2012-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3